Lissoclimides are cytotoxic compounds produced by shell-less molluscs through chemical secretions to deter predators. Chlorinated lissoclimides were identified as the active component of am arine extract from Pleurobranchus forskalii found during ah igh-throughput screening campaign to characterize new protein synthesis inhibitors. It was demonstrated that these compounds inhibit protein synthesis in vitro, in extracts prepared from mammalian and plant cells, as well as in vivo against mammalian cells. Our results suggest that they block translation elongation by inhibiting translocation, leading to an accumulation of ribosomes on mRNA. These data provide arationale for the cytotoxic nature of this class of small molecule natural products.
INTRODUCTION
Small molecule ligands that inhibit the process of translationh ave provided exquisite insight into ribosome function and translation factor activity in both prokaryotes and eukaryotes ( Pestka 1977; Vazquez 1979) . Inhibitors targeting as pecific step of proteins ynthesis havee nabled dissection of the translation pathway by allowing the characterization of events leading to the assembly of active polysomes, trapping intermediates of the initiation and elongation cycles, as well as providing insight into the molecular functions of protein factors ( Pestka 1977; Vazquez 1979) .R ecently, thereh as been renewed interest in identifyinga dditional inhibitors of translation as ac onsequence of trying to interdict this process in disease. Specifically, the ribosome recruitment phase of translation initiation is usurped in many human cancers (for review, see Mamanee ta l. 2004) . Hence, blocking signaling events that impingeo nt his process may have significant therapeutic potential (Wendel et al. 2004) .
Several inhibitors of elongation have been previously testeda sa nti-cancer agents in preclinical animal models and clinical trials. The selectivity of these general inhibitors for cancerc ells may stem from the fact that transformed cells have higher translation rates than do their nontransformed counterparts (Heys et al. 1991 ). Structureactivity relationship studies on two translation elongation inhibitors, sparsomycin and didemninB ,d emonstrated equivalent rank order potency for inhibition of translation inhibition andfor theiranti-proliferativeeffects (Ottenheijm and van den Broek 1988; van den Broek et al. 1989; Ahuja et al.2000) , indicating that the anti-tumoractivity of these compounds is ad irect consequenceo fp rotein synthesis inhibition. Currently, phase II clinical trials are in progress to assessthe efficacy of homoharringtonine (an inhibitor of translation elongation), with imatinib (a tyrosine kinase inhibitor that selectively targets the ABL, PDGFR, and KIT kinases) in chronic myeloidl eukemia( CML) or as salvage therapyi np atients with refractory acutep romyelocytic leukemia (see http://clinicaltrials.gov/ct).
We have undertaken ar esearch effort to identify novel inhibitors of eukaryotic translation based on the ability of smallm olecules to block translation in aK rebs-2 in vitro translation extractp rogramed with ab icistronic reporter (Novac et al. 2004 ). Extracts prepared fromKrebs-2ascites are well suited fort heses tudies because they faithfully recapitulate the cap-dependent and poly(A)-dependent features of in vivo translation (Svitkin andS onenberg 2004) . This screening campaign has lead to the identification of novel elongation (Chan et al.2004 ) and initiation (Bordeleau et al. 2005) inhibitors.
In the course of screeningextracts prepared frommarine organisms, we identifiedanextract active against both capdependent and IRES-mediatedtranslation. Bioassay-guided fractionationo ft he Pleurobranchus forskalii extract led to identificationo fc hlorolissoclimide and dichlorolissoclimide as the responsible inhibitory agents. Chlorolissoclimide and dichlorolissoclimide were first isolated in 1991 fromaNewC aledoniana scidian Lissoclinum voeltzkowi Michaelson,a nd in 2004, they were reisolatedf rom P. forskalii collected near St. Rosa in the Philippines (Malochet-Grivois et al. 1991; F ue ta l. 2004 ). The latter wast he first report of the isolation of Lissoclinum metabolites fromits predator P. forskalii .The mollusks are known to feed on ascidians. Chlorolissoclimide and dichlorolissoclimide arec ytotoxic bicyclicd iterpenea lkaloids effective against ar ange of transformed cell lines ( Malochet-Grivois et al. 1992; Roussakis et al. 1994; Uddin et al. 2001; Fuetal. 2004) . They are part of af amily of al arger class of natural molecules, referred to as labdanes, and for which no mode of action has yet been elucidated (Hanson 2005) . Herein, it is demonstrated that these compoundsa re potent inhibitors of eukaryotic translation elongation.T heyc ause accumulation of ribosomes on mRNA templates and interfere with the translocations tep of elongation.
RESULTS AND DISCUSSION
By utilizing ah igh-throughput screen in which the translational output of abicistronic mRNA encoding firefly (FF) and renilla( Ren) luciferases (lucs) is monitored, we have screened al arge collection of natural product extracts (Novac et al. 2004) . During the course of this screen, we identified an inhibitory activity in extracts derived from the marine slug, P. forskalii. Bioassay-guided fractionation identified two active components, chlorolissoclimidea nd dichlorolissoclimide (Fig. 1A) . When tested in Krebs-2 extracts programedw ith FF/HCV/Renm RNA ( Fig.1 B) , both compounds exerted ad ose-dependenti nhibition of translation from the FF and Renl uc cistrons ( Fig. 1C,D) . Chlorolissoclimide appeareds lightly more potent at inhibiting protein synthesis (IC 50 = z 0.7 m M) comparedw ith dichlorolissoclimide (IC 50 = z 1.25 m M). Chlorolissoclimide was also active in translation extracts from rabbit reticulocyte lysates (Fig. 1E ) and wheat germ extracts (Fig.  1F ). Dichlorolissoclimidew as also active in these extracts, although with an approximately twofold higher IC 50 (data not shown). Neither chlorolissoclimide nor dichlorolissoclimideinhibited translations in Escherichiac oli S30extracts or exerted an effect on bacterial growth (data not shown).
To identify the phase of translation at which chlorolissoclimide is exerting its inhibitory effect, we assessed the ability of this compound to inhibit initiation complex formationi nt he presence of cycloheximide (Fig.2 A) . The failure to prevent 80S complexf ormation indicates that chlorolissoclimide is not blocking translation initiation. On its own, chlorolissoclimide is capableo ft rapping an 80S ribosome on an mRNA template, suggesting that the compound is inhibiting translation by blocking the elongation phaseo ft ranslation (Fig. 2B ). To assessi fa ctively translating ribosomes are sensitive to chlorolissoclimide or if only newly initiatedr ibosomes were being targeted by this compound, it wasadded to aKrebs extracts 5min after the start of translation (Fig.2 C) . Immediate cessation of protein synthesis was observed with chlorolissoclimide and cycloheximide (Fig. 2C) . These results indicate that chlorolissoclimide immediately blocks elongation and does not allow ribosomes to run-off the mRNA template, in which case a2 -t o3 -min delay in the onset of inhibition would be expected ( Chan et al. 2004) .
We characterizedthe events during elongation that might be affected by chlorolissoclimide by analyzingv arious steps of the process. We assessed the ability of these compounds to interfere with eEF1A-dependent aminoacyl-tRNA delivery, peptidyl transferase, and eEF2-dependent translocation by using salt-washedr ibosomes isolated fromr abbit reticulocytes lysate.C hlorolissoclimided id not inhibit eEF1A-dependent or nonenzymatic loading of aminoacyltRNA onto ribosomes (Table 1) . Also, the compound had no effect on the peptidyl transferaser eaction since the amounts of 35 S-Met-puromycin dipeptide produced in the absenceo rp resence of chlorolissoclimidew ere similar (Fig. 2D) . However, inhibition of eEF2 dependent and eEF2-independent translocation was observed by chlorolissoclimide,s imilar to what wasn oted with cycloheximide (Table1 ). The obtained luciferase activities were normalized to the activity obtained in the control translations (0.5% methanol) of the same mRNA species (which was set at one). Each data point represents the average of three translations, and the SEM is shown. ( Bottom)T he protein products were analyzed by SDS-PAGE, which were subsequently treated with EN 3 Hance, dried, and exposed to X-OMAT film (Kodak). The positions of migration of the firefly and renilla products are indicated by arrows and arrowheads, respectively. ( D )T ranslation mediated by cap-dependent and HCV-driven translation is sensitive to the presence of dichlorolissoclimide in Krebs-2 cell extracts. ( E )I nhibition of translations in rabbit reticulocyte lysate by chlorolissoclimide. Translation data and products were processed and analyzed as in C .(F )Chlorolissoclimide inhibits cap-dependent translation in wheat germ extracts. Translation data and products were processed and analyzed as in C .
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To determine whether chlorolissoclimide could inhibit cellular protein synthesis in vivo, and to establish the selectivity of this compound, we exposed HeLa cells to increasing concentrationso fc hlorolissoclimide and monitored protein, RNA, and DNA synthesis (Fig. 3A) . In this experiment, protein synthesis was dramatically inhibited, whereas DNA synthesis was only slightly affected (30% inhibition) (Fig. 3A) . RNA transcription was not affected under ourexperimental conditions (Fig. 3A) . The observed protein synthesis inhibition was reversible, since following washout of compound, it took z 4hforc ells to recover fromthe inhibitory effects of the compound (Fig. 3B) . This contrasts to the 1-h recovery period required for cells exposed to anisomycin (Fig.3 B) . Treatment of cells with chlorolissoclimide did not lead to al oss of polysomes but rather was consistent with ab lock in elongation in which ribosomes were stalled on them RNA template (Fig. 3C ). This mechanism of action differs froms ome other inhibitors of elongation, such as phyllanthosidea nd nagilactone C, in which inhibit of elongation results in ad isruption of polysomes (Chan et al. 2004) . As expected,a nisomycin blockede longation and trapped ribosomes in polysomes (Grollman 1967) .
The results presented in this studye xplain the cytotoxicity associatedw ith chlorolissoclimides (Malochet-Grivois et al. 1992; Roussakis et al. 1994; Uddin et al. 2001; Fu et al. 2004) . We note ad egree of structural similarity between lissoclimides and cycloheximide, as pecific inhibitor of eukaryotic translation that interferes with ribosomal E-site function and blocks translocation (Obrig et al. 1971; Pestova and Hellen 2003) . Similar to cycloheximide, lissoclimides block elongation and do not allow release of P-radiolabeled CAT mRNA was then added to the reaction, and the incubation continued for an additional 10 min at 30°C. Translation complexes were resolved by centrifugation through 10%-30% glycerol gradients. Total counts recovered from each gradient and the percentage mRNA bound in 80S complexes were as follows: CAT mRNA/CHX, 17.3%; CAT mRNA/CHX +c hlorolissoclimide, 18.4%. ( B )C hlorolissoclimide can trap ribosomes on mRNA templates. Rabbit reticulocyte lysate were preincubated with 50 uM chlorolissoclimide for 5min at 30°C. ribosomes fromp olysomes. Chlorolissoclimides are members of alarger family of diterpenoids, called labdanes, that also show significanta ctivity against manye ukaryotic organisms (Hanson 2005) . For instance, norditerpenes aldehydes isolated fromt he shrub Vitex trifolia showed potent activity against Trypanosomac ruzi,t he causative agento fA merican trypanosomiasis (Kiuchi et al. 2004 ). Also afuranolabdane extracted from the plant Potamogeton lucens is ap otent algicide (Waridel et al. 2004 ), while as imilar compoundi solated from Hypoestes purpurea is cytotoxic to carcinoma cell lines ( Shen et al. 2004) . Although direct evaluation of thesecompounds is required to determine if they also inhibit protein synthesis, this modeo fa ction may be ac ommon defense approach mechanism utilized by aw ide range of organismst ow ard off predators.
MATERIALS AND METHODS

Materials andg eneral methods
Restriction endonucleases and T7 RNA polymerase were purchased from New England Biolabs. 5-3 H-cytidine triphosphate (20.5 Ci/mmol), 35 S-methionine (>1000 Ci/mmol), 5-3 Huridine (22 Ci/mmol), and 6-3 H-thymidine (10 Ci/mmol) were obtained from Perkin Elmer Life Sciences. Preparation of plasmid DNA, restriction enzyme digestions, agarose gel electrophoresis of DNA and RNA, and SDS-PAGE analysis were carried out by using standard methods (Sambrook and Russell 2001) . Chlorolissoclimide anddichlorolissoclimidewerepurifiedfrom25mg P. forskalii extract. The extract was subjected to reverse-phase HPLC (Phenomenex, Prodigy ODS 5 m ,2 50 3 10 mm) by using ag radient elution system from 100% water to 100% acetonitrile. Purification of the active fractions was performed by using normal-phase HPLC (PhenomenexLunasilica(2) 5 m ,250 3 4.6mm, l 254nm) using ag radient system from 100% hexane to 100% dichloromethane. Am ixture of chlorolissoclimide and dichlorolissoclimide was obtained, and the compounds were separated by using reverse-phase HPLC (Phenomenex Luna C18 5 m ,150 3 4.6 mm) using aw ater/methanol gradient system. Chlorolissoclimide wase lutedf irst followedb yd ichlorolissoclimide at 88% MeOH/H 2 O.
The identity of the purified compounds was established by 1 H-NMR measurement and mass spectrometry and by compar- 
In vivo metabolic labeling studies
For metabolic labeling studies, HeLa cells were incubated in the presence of compound or vehicle alone for the indicated amounts of time.
35
S-methionine (150-225uCi/mL), 3 H-uridine (24uCi/mL), or 3 H-thymidine (48 uCi/mL; Perkin Elmer Life Sciences) was added to cells. For protein labeling, 35 S-methionine was added in methionine-free media supplemented with 10% dialyzed FCS. For 3 H-uridine and 3 H-thymidine labeling, the isotopes were added in DMEM supplemented with 10% dialyzed FCS. Cells were washed once with phosphate-buffered saline, trypsinized, and harvested by centrifugation. The supernatant was removed by aspiration and the cell pellet was lysed in RIPA buffer (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). For determination of 35 S-methionine incorporation, the lysate was spotted onto Whatman 3MMpaper (that had been preblocked with 503 amino acids mix) (Invitrogen), dried, and placed in cold 10% TCA for 20 min. Filters were transferred to 5% TCA, boiled for 15 min, washed once with 5% TCA and once with 95% ethanol, and dried. Radioactivity was determined by scintillation counting. The obtained counts were normalized to protein concentration in each sample, which had been determined by using am odified Lowry assay (DC Protein Assay; Bio-Rad). Translocation assays were performed in presence or absence of eEF2 with Phe-tRNApreloaded eEF1A, as described by Chan et al. (2004) . The translocation of the tRNA wasdeterminedbymonitoringthe amount of puromycin reactivePhe-tRNAbound to the ribosomal P-site following translocation. Theo btained values are correctedf or P-site reactive [ For detection of radiolabeled nucleic acid, 5% TCA was added to the lysate supplemented with 9 m go fy east tRNA. This was incubated for 20 min at 4°C, after which the solution was filtered through aG F/C glass fiber filter (Whatman; preblocked with 0.1Msodium pyrophosphatein5%TCA,washedtwice with 5mL of 1% TCA, and rinsed with 95% ethanol. After drying, radioactivity was determined by scintillation counting. The obtained counts were normalized to the protein concentration in each sample (determined using am odified Lowry assay; DC Protein Assay; Bio-Rad).
In vitro translations
In vitro translation assays were performed with abicistronic mRNA reporter, FF/HCV/ Ren, in which the first cistron encodes the FF luc protein and the second cistron encodes the Ren luc protein (Fig. 1B) . Expression of the second cistron is driven by HCV IRES sequences. In vitro transcriptions were performed by using BamHI linearized templates. Translations were performed in Krebs extracts as previously reported (Novac et al. 2004) . Translations in rabbit reticulocyte lysate, wheat germ extracts, and E. coli S30 extracts were performed as recommended by the manufacturer (Promega Corp). FF and Ren luc activity (RLU) were measured on aBerthold Lumat LB 9507 luminometer.
Ribosomeb inding assays
Ribosome binding assays were performed by incubating 32 P-labeledm RNAi n2 5 m L of rabbit reticulocyte lysate (Promega) for 10 min at 30°Ci nt he presence of 50 m M chlorolissoclimide with or without 0.6 mM cycloheximide. The final potassium acetate concentration was adjusted to 150 mM. Initiation complexes formed were analyzed by sedimentation through 10%-30% glycerol gradients. Centrifugation was for 3.5 h at 39,000 rpm at 4°Ci na nS W40 rotor. Fractions of 500 m Lw ere collected, and radioactivity was determined by Cherenkov counting in al iquid scintillation counter. The plasmid pSP6/CAT used to generate mRNA for binding experiments has been previously described (Svitkin et al. 2001 ).
Met-puromycin dipeptide assays
Met-puromycin dipeptide assays were performed essentially as previously described (Lorsch and Herschlag 1999) . Briefly, reactions included 60 nM ribosomes, 2n M 35 S-methionyl-tRNA, 400 m Mp uromycin, and 1 m Mm odel mRNA, in ab uffer containing 500 m MG TP, 1.75 mM magnesium acetate, and other components as previously described (Lorsch and Herschlag 1999) . 80S complexes were preformed prior to addition of puromycin and inhibitor. Reactions proceeded for 30 min at 26°C, with aliquots removed periodically and quenched in 3M sodium acetate (pH 5.1). Quenched samples were resolved by cationexchange TLC and 35 S-Met-puromycin product quantitated. The observed rate constant at several concentrations of inhibitor was measured and normalized to ap ositive control reaction performed in the absence of inhibitor. ( C )C hlorolissoclimide does not disrupt cellular polysomes. HeLa cells were incubated for 1hwith 50 uM of chlorolissoclimide, after which the cells were washed twice with PBS, harvested with ar ubber policeman, and collected by brief centrifugation. The cell pellet was resuspended in lysis buffer (5 mM TrisHCl at pH 7.5, 2.5 mM MgCl 2 ,1 .5 mM KCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 2m MD TT), vortexed, and centrifuged for 2m in at 14,000g .T he supernatants were loaded onto 10%-50% sucrose gradients prepared in 20 mM Hepes (pH 7.6), 100 mM KCl, and 5m MM gCl 2 and centrifuged in an SW40 at 35,000 rpm for 2h .G radients were analyzed by piercing the tube with aBrandel tube piercer, passing 60% sucrose through the bottom of the tube, and monitoring the absorbance of the material eluting from the tube using an ISCO UA-6 UV detector.
eEF1A-ande EF2-dependent assays
Phe-tRNA Phe was prepared as previously described (Odom et al. 1990) , except that yeast S100 was used as as ource of tRNA synthetase. The tRNA was further purified by passage through aS ephadex G-50 column. Both enzymatic and nonenzymatic aminoacyl-tRNA binding experiments were performed following ap ublished procedure (SirDeshpande and Toogood 1995). Reaction mixtures containing HEPESbuffer(20 mM HEPES-KOHat pH 7.5, 10 mM MgCl 2 ,1 00 mM KCl, 1.0 mM DTT), 89 pmol of 80Sribosomeand inhibitorincubated for10min at 37°C; 0.15 mM GMPPNP, 0.2 m go fp oly(U), 2.3 m go fe EF1A, and 10 pmol of [
14 C]Phe-tRNA Phe was then added and incubated for another 30 min at 37°C. To determine the amount of ribosome bound [
14 C]Phe-tRNA Phe ,t wo aliquots (10%) of the assay mixture were removed, diluted with 0.8 mL of HEPES buffer, and filtered through aM illipore Type HA nitrocellulose filter. The filter was rinsed with the same buffer (5 3 2m L), dried, and counted.
To measure nonenzymatic binding of [ 14 C]Phe-tRNA Phe to ribosome, 177 pmol of 80S ribosome was preincubated with inhibitor in the presence of Tris-HCl buffer (50 mM Tris-HCl at pH 7.5, 60 mM KCl) and 20 mM MgCl 2 at 37°Cf or 10 min; poly(U) (40 m g) and [
14 C]Phe-tRNA Phe were incubated at 37°C for 30 min. Two aliquots constituting 10% of the reaction mixture were removed and diluted into 0.8 mL of Tris-HCl buffer containing 20 mM MgCl 2 and filtered through aT ype HA nitrocellulose filter. The filter was rinsed with the same buffer (2 3 5m L), dried, and counted to measure the amount of ribosome bound [
14 C]Phe-tRNA Phe . eEF1A-dependent [
14 C]Phe-tRNA Phe binding to 89 pmol of ribosome was performed as described above. The amount of P-site bound [ 14 C]Phe-tRNA Phe was determined for an identical sample by using the puromycin reaction (Wurmbach and Nierhaus 1979) . To determine the inhibition of translocation, inhibitors were added into the rest of the 80% reaction mixture and incubated for 10 min at 37°C. Then, eEF2 (0.13 m g), HEPES buffer to compensate with the reaction volume, and 0.5 mM puromycin were added followed by 1m MG TP to initiate translocation. Following incubation for an additional 30 min at 37°C, two aliquots (10%) of reaction mixture were quenched in 30 m Lo f 1m Ms odium bicarbonate (pH 5.1), and the amount of P-site bound [
14 C]Phe-tRNA Phe was determined by extraction of [ 14 C]phenylalanine-puromycin into ethyl acetate (1 mL) and corrected for the amount of tRNA present in the P-site before translocation. The amount of radioactivity was measured by scintillation counting of 900 m La liquots of the organic layer.
